CPHI 2026 Preview

As demand for global biologics manufacturing continues to grow, developers are seeking greater flexibility, speed and supply resilience. In this webinar, George Sakellariou, Vice President, Global Account Management shares how FUJIFILM Biotechnologies’ recent investments across its global CDMO network are helping customers accelerate development, reduce risk, and support commercial success.

Key points include:

• Process development and mid-scale manufacturing solutions that enable flexibility and supply security
• Large-scale global drug substance manufacturing capabilities
• Recent investments and expanded capabilities in Hillerod, Denmark
• Holly Springs selection in FDA PreCheck Pilot Program